Sign In
Buy ACST
$3.37
+0 (+0%)
At Close: Jan 24, 2025
ACST Stock: 13 Things to Know as Acasti Pharma Shares Soar 100%
01:22pm, Wednesday, 23'rd Dec 2020
ACST stock is up more than 100% on Wednesday without any news about Acasti Pharma. Here's what you should know.
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2021
06:55am, Monday, 16'th Nov 2020
LAVAL, Quebec, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) today provided a business update and announced its operating and fin
What Makes Acasti (ACST) a New Buy Stock
04:00pm, Friday, 14'th Aug 2020
Acasti (ACST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021
12:30pm, Thursday, 13'th Aug 2020
On track to report TRILOGY 2 topline data on or about August 31, 2020LAVAL, Quebec, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST)
LAVAL, Quebec, July 31, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development
Why Acasti Pharma's Stock Is Trading Higher Today
06:37pm, Monday, 06'th Jul 2020
Acasti Pharma (NASDAQ: ACST) shares are trading higher on Monday after B.Riley FBR upgraded the stock from Neutral to Buy and announced a price target of $2 per share.Acasti Pharma is a biopharmaceuti
Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q4 2020 Results - Earnings Call Transcript
08:08pm, Monday, 29'th Jun 2020
Acasti Pharma Inc. (NASDAQ:ACST) Q4 2020 Earnings Conference Call June 29, 2020 10:30 AM ET Company Participants Alexandra Botie - Crescendo Communications, LLC
Acasti Pharma Provides Fiscal 2020 Year-End Business Update
01:45pm, Monday, 29'th Jun 2020
Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug
Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing Package
12:00pm, Friday, 19'th Jun 2020
LAVAL, Québec, June 19, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, develo
Hedge Funds Souring On Acasti Pharma Inc. (ACST)
01:49am, Friday, 05'th Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filing
Aegis Capital Maintains Buy on Acasti Pharma, Lowers Price Target of $2.15
04:35pm, Wednesday, 06'th May 2020Does The Acasti Pharma Inc. (CVE:ACST) Share Price Fall With The Market?
10:25am, Wednesday, 06'th May 2020
Anyone researching Acasti Pharma Inc. (CVE:ACST) might want to consider the historical volatility of the share price...
Acasti Pharma Announces Submission Of TRILOGY 1 Briefing Package To FDA
12:30pm, Thursday, 30'th Apr 2020Acasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDA
12:30pm, Thursday, 30'th Apr 2020
Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug
